NCT06161233
Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy No drug interventions supportive_care Not Available completed NCT03905889
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma treatment 1 terminated NCT05548621
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC) No drug interventions Not Available Not Available recruiting NCT03699579
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC No drug interventions Not Available Not Available completed NCT04764487
A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line No drug interventions prevention 3 recruiting NCT03977571
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial No drug interventions treatment Not Available recruiting NCT05103722
Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma No drug interventions supportive_care Not Available terminated NCT06377722
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer treatment 2 terminated NCT06321250
A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma No drug interventions treatment 1 recruiting NCT04659343
TDM for Optimized Outcome in Patients With mRCC. No drug interventions Not Available Not Available recruiting NCT06601296
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer No drug interventions treatment 2 not_yet_recruiting NCT04115189
A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA) Not Available Not Available completed NCT05287464
International Multicentric Study ARON-1 Not Available Not Available recruiting NCT01390519
A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor No drug interventions Not Available Not Available completed NCT02184416
Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting No drug interventions Not Available Not Available completed NCT01514448
Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib treatment 4 completed NCT04175262
Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments Not Available Not Available completed NCT05119335
A Study of NKT2152, a HIF2α Inhibitor, in Patients with Advanced Clear Cell Renal Cell Carcinoma No drug interventions treatment 1 / 2 active_not_recruiting NCT06500455
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain No drug interventions treatment 3 recruiting NCT06607809
Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC No drug interventions Not Available Not Available completed NCT03055013
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy treatment 3 active_not_recruiting NCT04514484
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV treatment 1 active_not_recruiting NCT03595124
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) treatment 2 active_not_recruiting NCT03647878
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment. No drug interventions Not Available Not Available recruiting NCT05092373
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax treatment 1 recruiting NCT05155033
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma treatment 2 recruiting NCT06626256
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma treatment 1 not_yet_recruiting NCT04588246
Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery treatment 3 terminated NCT04974671
Trial of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma No drug interventions treatment 2 recruiting NCT05263050
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors treatment 2 recruiting NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs No drug interventions treatment 1 recruiting NCT06284564
A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC) treatment 2 recruiting NCT04467021
Cancer and Blood Pressure Management, CARISMA Study No drug interventions treatment Not Available active_not_recruiting NCT02089802
Optimizing Pazopanib Exposure in RCC Patients treatment 2 terminated NCT03541902
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma treatment 2 active_not_recruiting NCT02187302
CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC) treatment 2 completed NCT01517243
Phase II Study of Alternating Sunitinib and Temsirolimus treatment 2 completed NCT04076787
Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib Not Available Not Available completed NCT02056587
Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment treatment 4 completed NCT00930033
Clinical Trial to Assess the Importance of Nephrectomy No drug interventions treatment 3 completed NCT01827254
Sutent Rechallenge In mRCC Patients No drug interventions Not Available Not Available completed NCT02926053
TIL Therapy for Metastatic Renal Cell Carcinoma treatment 1 unknown_status NCT06132945
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain treatment 1 recruiting NCT04712305
Urine Omics Predicting IO Therapy Responses in mRCC Patients No drug interventions Not Available Not Available recruiting NCT02330783
Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients treatment 2 unknown_status NCT05700461
Drug Screening Using Novel IMD in Renal Cell Carcinoma No drug interventions treatment 1 recruiting NCT03071328
INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers other 0 completed NCT01444807
Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases treatment 2 unknown_status NCT00630409
Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma treatment 2 completed NCT01482156
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors treatment 1 completed NCT00554515
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma treatment 2 completed NCT00142415
Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer treatment 1 / 2 completed NCT01266837
Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2) treatment 4 completed NCT02789137
Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment No drug interventions Not Available Not Available completed NCT01202032
Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors treatment 1 completed NCT02398552
A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma. treatment 2 unknown_status NCT03149159
Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab treatment 2 withdrawn NCT02298959
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer treatment 1 active_not_recruiting NCT01481870
Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma treatment 3 unknown_status NCT04337970
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer treatment 1 / 2 active_not_recruiting NCT01100242
Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma treatment 2 terminated NCT01182142
Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients treatment 2 completed NCT03519542
Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma Not Available Not Available completed NCT05858749
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC). No drug interventions Not Available Not Available completed NCT02595918
Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery treatment 1 terminated NCT05259319
Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT) treatment 1 recruiting NCT00740441
A Phase II Study of AS1411 in Renal Cell Carcinoma treatment 2 unknown_status NCT02944617
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor No drug interventions supportive_care Not Available completed NCT01525017
A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer No drug interventions treatment 1 completed NCT02599324
Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors treatment 1 / 2 completed NCT03494816
Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion treatment 2 completed NCT02035358
Immunotherapy Study for Metastatic Renal Cell Cancer No drug interventions treatment 1 completed NCT02849535
Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer No drug interventions supportive_care Not Available unknown_status NCT01977586
Functional Imaging in the Assessment of mRCC Response to Sunitinib No drug interventions diagnostic Not Available withdrawn NCT01673386
A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC treatment 2 terminated NCT03589339
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy treatment 1 recruiting NCT03927248
PAC-1 for Treatment of Refractory, Metastatic Kidney Cancer treatment 1 / 2 withdrawn NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT00203866
Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma No drug interventions treatment 2 terminated NCT04603365
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer treatment 2 withdrawn NCT03091465
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib No drug interventions Not Available Not Available completed NCT04961320
Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell Carcinoma No drug interventions supportive_care Not Available withdrawn NCT04068831
Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma treatment 2 completed NCT01274273
Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer treatment 2 unknown_status NCT01223027
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma treatment 3 completed NCT05112627
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy No drug interventions Not Available Not Available completed NCT04262427
The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma treatment 1 / 2 unknown_status NCT03140176
Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy. Not Available Not Available terminated NCT00357760
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer treatment 2 completed NCT01689662
Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma No drug interventions other 2 completed NCT03587662
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer treatment 2 active_not_recruiting NCT01073644
Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients Not Available Not Available terminated NCT04049344
Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma treatment 2 unknown_status NCT01415167
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy No drug interventions Not Available Not Available completed NCT03115801
A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers treatment 2 terminated NCT01152801
Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer treatment 1 completed NCT01491672
Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma treatment 2 completed NCT01582672
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma treatment 3 terminated NCT02150369
Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms No drug interventions Not Available Not Available completed NCT00421512
A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients treatment 1 completed NCT05119010
A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma No drug interventions treatment Not Available recruiting NCT06361810
PSMA Therapy and Immunotherapy in Kidney Cancer treatment 1 / 2 not_yet_recruiting NCT00318110
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma No drug interventions treatment 2 terminated NCT04090710
SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer treatment 2 active_not_recruiting NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors treatment 1 / 2 recruiting NCT03463681
A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma treatment 2 completed NCT04788095
App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer No drug interventions device_feasibility Not Available active_not_recruiting NCT02419495
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies treatment 1 active_not_recruiting NCT00709995
A Study for Participants With Metastatic Renal Cell Carcinoma treatment 2 completed NCT00444314
Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma treatment 2 completed NCT01028638
Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT03138538
M8891 First in Human in Solid Tumors No drug interventions treatment 1 terminated NCT03692338
INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell Carcinoma No drug interventions supportive_care Not Available terminated NCT05817903
Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients treatment 2 recruiting NCT02122003
Second Line Sorafenib After Pazopanib in Patients With RCC treatment 2 terminated NCT02406521
Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets treatment 1 completed NCT01577784
Pazopanib in Second-line Therapy in Renal Cell Carcinoma treatment 2 unknown_status NCT02282579
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy Not Available Not Available completed NCT02447887
Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) treatment 1 / 2 terminated NCT01136733
A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment treatment 1 / 2 completed NCT02959554
Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control treatment 2 terminated NCT05863351
Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study No drug interventions treatment 3 recruiting NCT01219751
Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma treatment 2 unknown_status NCT04693377
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial No drug interventions supportive_care Not Available recruiting NCT00684645
Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT® Not Available Not Available completed NCT00151645
Efficacy of Activated Lymphocytes in Renal Cell Carcinoma. No drug interventions treatment 2 terminated NCT04462445
Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb treatment 2 completed NCT00930345
Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma treatment 4 terminated NCT03729245
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) treatment 3 terminated NCT04510597
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial No drug interventions treatment 3 recruiting NCT00515697
A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma treatment 2 completed NCT03474497
UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade treatment 1 / 2 recruiting NCT03575611
Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma No drug interventions treatment 2 suspended NCT03829111
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer treatment 1 completed NCT00068393
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma treatment 2 completed NCT01784978
Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer treatment 2 terminated NCT03284385
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 treatment 2 active_not_recruiting NCT03891485
Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy No drug interventions Not Available Not Available recruiting NCT02864615
Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy No drug interventions treatment Not Available completed NCT05135832
Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma No drug interventions supportive_care Not Available unknown_status NCT02867332
PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma. treatment 1 withdrawn NCT04644432
Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma No drug interventions treatment 2 unknown_status NCT03408652
Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies supportive_care 3 terminated NCT02774200
A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. treatment 2 unknown_status NCT05816642
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma screening Not Available recruiting NCT06391099
Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT02231749
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214) treatment 3 active_not_recruiting NCT00913913
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients treatment 2 terminated NCT05219318
Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors No drug interventions treatment 3 recruiting NCT06399419
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer treatment 1 recruiting NCT02071641
Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma treatment 2 terminated NCT03200717
Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment treatment 2 completed NCT03428217
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma treatment 2 completed NCT00410124
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib treatment 3 completed NCT04802824
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT No drug interventions Not Available Not Available recruiting NCT03786796
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations treatment 2 recruiting NCT01731158
Sequential Therapy in Metastatic Renal Cell Carinoma treatment 2 completed NCT00942058
Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer No drug interventions Not Available Not Available terminated NCT03013335
Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen treatment 2 completed NCT05327686
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study treatment 2 recruiting NCT03967522
Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases treatment 2 recruiting NCT03149822
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma treatment 1 / 2 active_not_recruiting NCT04919122
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma No drug interventions Not Available Not Available recruiting NCT04508725
Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) diagnostic Not Available active_not_recruiting NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) treatment 2 recruiting NCT00606866
MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma treatment 3 completed NCT01689766
Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma other 2 completed NCT00414765
Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma treatment 4 completed NCT00570882
Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC) treatment 2 completed NCT02639182
A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma treatment 2 completed NCT03126331
Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab treatment 2 completed NCT05796973
Measuring Oncological Value of Exercise and Statin treatment 3 recruiting NCT01342627
Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma treatment 2 terminated NCT02026960
RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017) No drug interventions device_feasibility Not Available terminated NCT02837991
A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma No drug interventions treatment 1 terminated NCT03682289
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors treatment 2 recruiting NCT00531544
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248 treatment Not Available completed NCT00848640
Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma treatment 2 completed NCT06548867
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib Not Available Not Available recruiting NCT01550367
Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC) treatment 1 / 2 completed NCT01265901
IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma treatment 3 completed NCT00619268
Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma treatment 2 completed NCT00625768
Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma treatment 1 completed NCT00291369
Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis treatment 3 completed NCT05122546
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer treatment 1 active_not_recruiting NCT04299646
Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases No drug interventions treatment 2 recruiting NCT03379012
Testosterone in Metastatic Renal Cell Carcinoma Patients treatment 2 completed NCT01033981
Cost Effectiveness Of Sunitinib In Central America And Caribbean Not Available Not Available terminated NCT01441414
PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma treatment 2 terminated NCT01917214
A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival No drug interventions Not Available Not Available completed NCT04891055
Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial) No drug interventions Not Available Not Available unknown_status NCT03075423
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC treatment 2 active_not_recruiting NCT05759923
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours No drug interventions treatment 1 recruiting NCT03013946
Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy No drug interventions supportive_care 3 recruiting NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) treatment 1 active_not_recruiting NCT03562507
Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma treatment 2 terminated NCT03991130
High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma treatment 2 recruiting NCT02432846
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) treatment 2 completed NCT06648902
Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue No drug interventions supportive_care 1 / 2 completed NCT06264479
Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2 No drug interventions Not Available Not Available not_yet_recruiting NCT05326620
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) No drug interventions Not Available Not Available recruiting NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03095040
CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma treatment 3 unknown_status NCT03634540
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) treatment 2 active_not_recruiting NCT04749602
Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion. treatment 2 completed NCT01702909
Interleukin-2 in Metastatic Kidney Cancer treatment 2 terminated NCT01658813
5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer treatment 2 completed NCT03876925
A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC treatment 1 / 2 terminated NCT04368546
Sunitinib Treatment on Tissue Sodium Accumulation (TSS2) Not Available Not Available completed NCT01926990
Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT02542202
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer No drug interventions treatment Not Available terminated NCT01884961
Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2 No drug interventions treatment 2 active_not_recruiting NCT02579811
Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer treatment 2 completed NCT02318771
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer treatment 1 completed NCT02899078
Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer treatment 1 / 2 completed NCT02843607
Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer No drug interventions treatment 1 / 2 completed NCT01767636
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer treatment 2 active_not_recruiting NCT01829841
A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer treatment 2 completed NCT02626130
Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer treatment 0 completed NCT01258348
A Phase 1b Trial in Patients With Renal Cell Cancer treatment 1 completed NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors treatment 1 completed NCT00027820
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer treatment 1 / 2 completed NCT02599194
18F-FSPG PET/CT for Cancer Patients on Therapy diagnostic 2 completed NCT01462214
Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer treatment 1 / 2 completed NCT02664883
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03229278
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma treatment 1 completed NCT03092856
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer treatment 2 active_not_recruiting NCT00655252
Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy Not Available Not Available no_longer_available NCT02089334
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer treatment 1 / 2 terminated NCT00670748
Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer treatment 2 terminated NCT02555748
Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma other 4 completed NCT00428220
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. treatment Not Available completed NCT02689167
Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma treatment 2 unknown_status NCT01743469
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers treatment 2 completed NCT01590069
Aerosolized Aldesleukin in Treating Patients With Lung Metastases treatment 1 active_not_recruiting NCT01246843
Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib No drug interventions Not Available Not Available completed